BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16506958)

  • 1. Increased inflammatory markers in children with familial hypercholesterolaemia.
    Ueland T; Vissers MN; Wiegman A; Rodenburg J; Hutten B; Gullestad L; Ose L; Rifai N; Ridker PM; Kastelein JJ; Aukrust P; Semb AG
    Eur J Clin Invest; 2006 Mar; 36(3):147-52. PubMed ID: 16506958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
    van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
    J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating mononuclear cells nuclear factor-kappa B activity, plasma xanthine oxidase, and low grade inflammatory markers in adult patients with familial hypercholesterolaemia.
    Real JT; Martínez-Hervás S; García-García AB; Civera M; Pallardó FV; Ascaso JF; Viña JR; Chaves FJ; Carmena R
    Eur J Clin Invest; 2010 Feb; 40(2):89-94. PubMed ID: 20015244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of heterozygous familial hypercholesterolaemia in children.
    Nicholls DP; Cather M; Byrne C; Graham CA; Young IS
    Int J Clin Pract; 2008 Jul; 62(7):990-4. PubMed ID: 18492057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia.
    El Messal M; Beaudeux JL; Drissi A; Giral P; Chater R; Bruckert E; Adlouni A; Chapman MJ
    Clin Chim Acta; 2006 Apr; 366(1-2):185-9. PubMed ID: 16280123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES.
    Holven KB; Damås JK; Yndestad A; Waehre T; Ueland T; Halvorsen B; Heggelund L; Sandberg WJ; Semb AG; Frøland SS; Ose L; Nenseter MS; Aukrust P
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):200-5. PubMed ID: 16254204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia.
    Hedman M; Neuvonen PJ; Neuvonen M; Antikainen M
    Clin Pharmacol Ther; 2003 Aug; 74(2):178-85. PubMed ID: 12891228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
    Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
    Hedman M; Miettinen TA; Gylling H; Ketomäki A; Antikainen M
    J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of C-reactive protein and carotid intima media thickness in Taiwanese with familial hypercholesterolemia.
    Ye ZX; Cheng HM; Chiou KR; Charng MJ
    Am J Cardiol; 2008 Jul; 102(2):184-7. PubMed ID: 18602518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of pravastatin on blood lipids and serum high sensitive C-reactive protein in patients undergoing conventional coronary artery bypass grafting under on-pump: a clinical study of 81 cases].
    Wang XS; Mei YQ; Lu YF; Cai JZ; Ji Q; Tang CZ; Li TC; Hu DY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):101-4. PubMed ID: 18353213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Ryu SK; Hutten BA; Vissers MN; Wiegman A; Kastelein JJ; Tsimikas S
    J Clin Lipidol; 2011; 5(1):50-6. PubMed ID: 21262507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipids and neopterin in urine as new biomarkers of malnutrition and inflammation in the elderly.
    Hrnciarikova D; Hyspler R; Vyroubal P; Klemera P; Hronek M; Zadak Z
    Nutrition; 2009 Mar; 25(3):303-8. PubMed ID: 19019628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet.
    Weghuber D; Widhalm K
    Br J Nutr; 2008 Feb; 99(2):281-6. PubMed ID: 17697400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
    Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia.
    Lee WJ; Lee WL; Tang YJ; Liang KW; Chien YH; Tsou SS; Sheu WH
    Clin Chim Acta; 2008 Apr; 390(1-2):49-55. PubMed ID: 18201563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.